Although the Canadian cannabis market has evolved more slowly than expected, Canopy Growth Corp CGC has the potential to become a long-term leader in this sector, according to BofA Securities.
The Canopy Growth Analyst
Bryan Spillane reinstated coverage of Canopy Growth with a Buy rating and CA$30 ($21.61) price target.
The Canopy Growth Thesis
Canopy Growth’s recent developments, like management changes and "right-sizing" of operations, as well as its strong cash and market share position, make the company a good candidate to become a leader in the cannabis sector, Spillane said in a Friday note. (See his track record here.)
A robust balance sheet has allowed Canopy Growth to scale its business in both Canada and abroad faster than its peers, the analyst said.
While Canopy Growth had initially adopted a “be-first” approach, management now seems to be focusing on “striking a balance between growth, productivity and financial returns,” he said.
The company has already reduced capacity in Canada, scaling back the organization as well as some international projects, Spillane said.
While there are some near-term risks for Canopy Growth, like executing the roll-out of derivative product forms in Canada, these are “appropriately reflected in Street estimates and valuation on shares,” the analyst said.
CGC Price Action
Shares of Canopy Growth were trading 6.38% higher to $19.34 at the time of publication Friday.
Related Links:
Cannabis Stock Gainers And Losers From May 21, 2020
Seth Rogen's Houseplant Launches THC Beverages In Canada
Courtesy photo.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.